These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10900543)
1. A stability-indicating HPLC method to determine cyproterone acetate in tablet formulations. Segall A; Vitale M; Perez V; Hormaechea F; Palacios M; Pizzorno MT Drug Dev Ind Pharm; 2000 Aug; 26(8):867-72. PubMed ID: 10900543 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a reversed-phase liquid chromatographic method for analysis of estradiol valerate and medroxyprogesterone acetate in a tablet formulation. Segall A; Hormaechea F; Vitale M; Perez V; Pizzorno MT J Pharm Biomed Anal; 1999 Apr; 19(5):803-8. PubMed ID: 10698544 [TBL] [Abstract][Full Text] [Related]
3. A stability-indicating HPLC method to determine Celecoxib in capsule formulations. Dhabu PM; Akamanchi KG Drug Dev Ind Pharm; 2002 Aug; 28(7):815-21. PubMed ID: 12236067 [TBL] [Abstract][Full Text] [Related]
4. A new stability--indicating RP-HPLC method to determine assay and known impurity of Celecoxib API. Jadhav AS; Shingare MS Drug Dev Ind Pharm; 2005 Sep; 31(8):779-83. PubMed ID: 16221612 [TBL] [Abstract][Full Text] [Related]
5. HPLC method for the analysis of cyproterone acetate in tablets. Scott JC; Soltero RA J Chromatogr Sci; 1987 Sep; 25(9):415-7. PubMed ID: 2959678 [TBL] [Abstract][Full Text] [Related]
6. Atmospheric pressure photoionization applied to quantitation of cyproterone acetate in human plasma. Pereira AS; Mendes GD; Oliveira LS; Valle HF; De Nucci G J Chromatogr Sci; 2005; 43(10):513-7. PubMed ID: 16438790 [TBL] [Abstract][Full Text] [Related]
7. Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation. Ficarra R; Ficarra P; Tommasini S; Melardi S; Calabrò ML; Furlanetto S; Semreen M J Pharm Biomed Anal; 2000 Aug; 23(1):169-74. PubMed ID: 10898167 [TBL] [Abstract][Full Text] [Related]
8. Column reversed-phase high-performance liquid chromatographic method for simultaneous determination of rabeprazole sodium and domperidone in combined tablet dosage form. Sabnis SS; Dnvandev DN; Jadhav VY; Gandhi SV J AOAC Int; 2008; 91(2):344-8. PubMed ID: 18476346 [TBL] [Abstract][Full Text] [Related]
9. A new HPLC method to determine Donepezil hydrochloride in tablets. Pappa H; Farrú R; Vilanova PO; Palacios M; Pizzorno MT J Pharm Biomed Anal; 2002 Jan; 27(1-2):177-82. PubMed ID: 11682224 [TBL] [Abstract][Full Text] [Related]
10. A novel automated hydrophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals. Bertolini T; Vicentini L; Boschetti S; Andreatta P; Gatti R J Chromatogr A; 2014 Oct; 1365():131-9. PubMed ID: 25242223 [TBL] [Abstract][Full Text] [Related]
11. Cyproterone acetate quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization tandem mass spectrometry. Application to a comparative pharmacokinetics study. Borges NC; Mazuqueli A; Moreno RA; Astigarraga RB; Sverdloff CE; Galvinas PA; Sampaio MR; da Silva WM Arzneimittelforschung; 2009; 59(7):335-44. PubMed ID: 19728560 [TBL] [Abstract][Full Text] [Related]
12. Determination of cyproterone acetate in plasma samples by high-performance liquid chromatography. Zarghi A; Dadashzadeh S; Asgari A Boll Chim Farm; 2003 Jun; 142(5):220-2. PubMed ID: 14526655 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC. Arayne MS; Sultana N; Siddiqui FA Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713 [TBL] [Abstract][Full Text] [Related]
14. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets. Richheimer SL; Amer TM J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation. Kachhadia PK; Doshi AS; Joshi HS J AOAC Int; 2008; 91(3):557-61. PubMed ID: 18567301 [TBL] [Abstract][Full Text] [Related]
16. Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation. Calleri E; De Lorenzi E; Furlanetto S; Massolini G; Caccialanza G J Pharm Biomed Anal; 2002 Aug; 29(6):1089-96. PubMed ID: 12110394 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV. Al-Rimawi F Talanta; 2009 Oct; 79(5):1368-71. PubMed ID: 19635372 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation. Ram VR; Dave PN; Joshi HS J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089 [TBL] [Abstract][Full Text] [Related]
19. Development of stability-indicating HPLC method and accelerated stability studies for osmotic and pulsatile tablet formulations of Clopidogrel Bisulfate. Deshmukh PR; Gaikwad VL; Tamane PK; Mahadik KR; Purohit RN J Pharm Biomed Anal; 2019 Feb; 165():346-356. PubMed ID: 30579235 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms. El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]